Compliance Certificate under Reg. 74 (5) of SEBI (DP) Regulation 2018
Exchange summary
EarningsCanvas
Loading your research…
Opening the latest published company and exchange records.
EarningsCanvas
Opening the latest published company and exchange records.
NSE · NSE SME · BSE
Results, orders and company updates, with a trail back to the filing. Check the feed status below for freshness.
Exchange intelligence
An exchange could not be refreshed. These are last known disclosures. Check the official exchange for newer announcements.
Compliance Certificate under Reg. 74 (5) of SEBI (DP) Regulation 2018
The Exchange has sought clarification from Betala Global Securities Ltd on October 06, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded. The reply is awaited.
Beta Drugs Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Betala Global Securities Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 ,inter alia, to consider and approve Intimation of board meeting to consider unaudited financial results for the quarter ending 30th September 2026
Beta Drugs Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 30, 2026. Further, the company has informed the Exchange regarding voting results.